- ·Watch Axent Biosciences: the Monday email on marks, rounds and moves
Axent Biosciences funding history
No funding rounds for Axent Biosciences are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Axent Biosciences valuation
Axent Biosciences's last known valuation is $38 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.
How Axent Biosciences's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Axent Biosciences, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked about Axent Biosciences
- What is Axent Biosciences worth?
- Axent Biosciences's last known valuation is $38.0M.
- How much has Axent Biosciences raised?
- Axent Biosciences has raised $17.2M in total funding across its recorded rounds.